1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid has been researched along with Acute Confusional Senile Dementia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moursel, LG; Rotman, M; van Buchem, MA; van den Boogaard, ML; van der Graaf, LM; van der Maarel, SM; van der Weerd, L; Welling, MM | 1 |
1 other study(ies) available for 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blood-Brain Barrier; Brain; Disease Models, Animal; Fluorescent Antibody Technique; HEK293 Cells; Humans; Image Processing, Computer-Assisted; Immunoglobulin Fc Fragments; Immunoglobulin G; Indium Radioisotopes; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pentetic Acid; Positron-Emission Tomography; Presenilin-1; Radiopharmaceuticals; Single-Domain Antibodies; Tissue Distribution | 2015 |